Peptides AcademyTesamorelin + CJC-1295/Ipamorelin Fat Loss Stack
Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and receptor profiles. Tesamorelin has FDA-level RCT evidence for visceral fat reduction; CJC-1295/Ipamorelin amplifies nocturnal GH pulsatility for broader body composition support. The combination intensifies GH-mediated lipolysis across the day/night cycle.
Quick Comparison
| Property | peptide | The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin |
|---|---|---|
| Source | Salmon DNA fragments | Various sources |
| Primary Mechanism | A2A receptor activation, DNA repair | Varies by ingredient |
| Key Benefits | Tissue regeneration, anti-inflammation, collagen boost | Multiple skin benefits |
| Best Time to Apply | AM or PM | AM or PM |
| Can Combine? | Generally compatible — check specific guidelines. | |
How to Use Together
Tesamorelin 2 mg subcutaneously once daily in the morning (to leverage the diurnal GH pattern and avoid stacking with nocturnal pulse). CJC-1295 (no DAC) 100 mcg + Ipamorelin 100 mcg subcutaneously 30–60 minutes before bed on an empty stomach. The separation ensures distinct GH pulses rather than continuous elevation. Cycle: 8–12 weeks, with IGF-1 monitoring at baseline and 4–8 weeks.
Safety Notes
Both arms elevate IGF-1, which has theoretical cancer-promotion concerns at sustained supraphysiological levels. Monitor IGF-1 and maintain within upper-normal range for age. GH elevation can worsen insulin sensitivity — monitor fasting glucose and A1C. Contraindicated in active malignancy and uncontrolled diabetes. Water retention (edema, joint stiffness) is the most common side effect and usually resolves with time or dose reduction.
Recommended Products (3)
CJC-1295 + Ipamorelin
Research-Grade
The most widely used GHRH + GHRP stack — CJC-1295 extends GHRH half-life while Ipamorelin selectively amplifies GH pulses without disturbing cortisol or prolactin.
Ipamorelin
Research-Grade
The most selective GHRP (growth-hormone-releasing peptide) — amplifies GH pulses via ghrelin/GHSR receptor without meaningful cortisol, prolactin, or aldosterone crosstalk.
Tesamorelin
Egrifta
FDA-approved synthetic GHRH analog indicated for HIV-associated lipodystrophy, studied for visceral adipose tissue reduction and cognitive endpoints.
Frequently Asked Questions
Why combine Tesamorelin with CJC-1295/Ipamorelin instead of using one or the other?
How much fat loss should I realistically expect?
Why not just use a GLP-1 agonist instead?
Other peptide Ingredient Combinations
The Anti-Aging Stack: GHK-Cu + Epitalon
GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te…
The Cognitive Stack: Semax + Selank
The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression …
The GH Stack: CJC-1295 + Ipamorelin
The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo…
The Healing Stack: BPC-157 + TB-500
The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo…
Immune Support Stack
A combination approach targeting immune function through three complementary mechanisms: adaptive im…
The Longevity Stack: Epitalon + MOTS-c + SS-31
Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal…
The Metabolic Stack: GLP-1 + GHS
A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t…
The Sexual Health Stack: PT-141 + Kisspeptin-10
PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a…
The Sleep Stack: DSIP + Ipamorelin
DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio…